Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.
Document Type
Journal Article
Publication Date
1-15-2018
Journal
Lancet HIV
DOI
10.1016/S2352-3018(18)30003-1
APA Citation
Molina, J., Grund, B., Gordin, F., Williams, I., Schechter, M., & +several additional authors (2018). Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial.. Lancet HIV, (). http://dx.doi.org/10.1016/S2352-3018(18)30003-1
Peer Reviewed
1
